Quantum BioPharma Ltd.
QNTM
Price:
$9.85
Market Cap:
$37.60M
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
Stock Exchange
NASDAQ
Ticker
QNTM
PE Ratio
[-1.03]
ROE
[-289.99%]
Current Ratio
[0.78]
Dividend Yield
[0%]
Enterprise Value
[38.36M]
Dividend History
The PE Ratio as of December 2025 (TTM) for Quantum BioPharma Ltd. (QNTM) is -1.03
According to Quantum BioPharma Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -1.03. This represents a change of 77.24% compared to the average of -0.58 of the last 4 quarters.
Quantum BioPharma Ltd. (QNTM) Historical PE Ratio (quarterly & annually)
How has QNTM PE Ratio performed in the past?
The mean historical PE Ratio of Quantum BioPharma Ltd. over the last ten years is -964.33. The current -1.03 PE Ratio has changed -89.32% with respect to the historical average. Over the past ten years (40 quarters), QNTM's PE Ratio was at its highest in in the September 2018 quarter at 76.35. The PE Ratio was at its lowest in in the November 2016 quarter at -49343.77.
Average
-964.33
Median
-1.66
Minimum
-5019.13
Maximum
-0.29
Quantum BioPharma Ltd. (QNTM) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Quantum BioPharma Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.97%
Maximum Annual PE Ratio = -0.29
Minimum Annual Increase = -98.99%
Minimum Annual PE Ratio = -5019.13
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.29 | -85.52% |
| 2023 | -2.03 | 57.24% |
| 2022 | -1.29 | 28.06% |
| 2021 | -1.01 | 70.97% |
| 2020 | -0.59 | -53.48% |
| 2019 | -1.27 | -93.89% |
| 2018 | -20.79 | -59.19% |
| 2017 | -50.94 | -98.99% |
| 2016 | -5019.13 | 10.41% |
Quantum BioPharma Ltd. (QNTM) Average PE Ratio
How has QNTM PE Ratio performed in the past?
The current PE Ratio of Quantum BioPharma Ltd. (QNTM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.21
5-year avg
-1.04
10-year avg
-964.33
Quantum BioPharma Ltd. (QNTM) PE Ratio vs. Peers
How is QNTM’s PE Ratio compared to its peers?
Quantum BioPharma Ltd.’s PE Ratio is greater than Reviva Pharmaceuticals Holdings, Inc. (-1.16), greater than Annovis Bio, Inc. (-3.01), greater than Cumberland Pharmaceuticals Inc. (-10.06), greater than PolyPid Ltd. (-1.45), greater than Rockwell Medical, Inc. (-6.55), less than Rein Therapeutics Inc. (-0.61), less than Celularity Inc. (-0.65), less than BioAtla, Inc. (-1.02), greater than Actinium Pharmaceuticals, Inc. (-1.33), greater than Evaxion Biotech A/S (-9.76),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.16 | $42.95M | |
| -3.01 | $91.83M | |
| -10.06 | $33.50M | |
| -1.45 | $39.74M | |
| -6.55 | $34.44M | |
| -0.61 | $36.01M | |
| -0.65 | $47.87M | |
| -1.02 | $49.97M | |
| -1.33 | $45.86M | |
| -9.76 | $33.41M |
Build a custom stock screener for Quantum BioPharma Ltd. (QNTM) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quantum BioPharma Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Quantum BioPharma Ltd. (QNTM) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Quantum BioPharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Quantum BioPharma Ltd.'s PE Ratio?
How is the PE Ratio calculated for Quantum BioPharma Ltd. (QNTM)?
What is the highest PE Ratio for Quantum BioPharma Ltd. (QNTM)?
What is the 3-year average PE Ratio for Quantum BioPharma Ltd. (QNTM)?
What is the 5-year average PE Ratio for Quantum BioPharma Ltd. (QNTM)?
How does the current PE Ratio for Quantum BioPharma Ltd. (QNTM) compare to its historical average?